These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32329899)

  • 61. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma.
    Unadkat P; Olumi AF; Gershman B
    Urol Clin North Am; 2020 Aug; 47(3):371-377. PubMed ID: 32600538
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.
    Schafhauser W; Ebert A; Brod J; Petsch S; Schrott KM
    Anticancer Res; 1999; 19(2C):1573-8. PubMed ID: 10365148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
    Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
    J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery.
    Battaglia M; Ditonno P; Martino P; Palazzo S; Annunziata G; Selvaggi FP
    Scand J Urol Nephrol; 2004; 38(4):306-14. PubMed ID: 15669590
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of lymph node dissection in patients with ≥7-cm renal tumors.
    Feuerstein MA; Kent M; Bazzi WM; Bernstein M; Russo P
    World J Urol; 2014 Dec; 32(6):1531-6. PubMed ID: 24402173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
    Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
    BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal cell carcinoma in children and adolescence: our experience.
    Kumar S; Sharma P; Pratap J; Tiwari P; Bera MK; Kundu AK
    Afr J Paediatr Surg; 2014; 11(2):101-4. PubMed ID: 24841006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
    Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
    Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of lymph node dissection in renal cell cancer.
    John NT; Blum KA; Hakimi AA
    Urol Oncol; 2019 Mar; 37(3):187-192. PubMed ID: 29602639
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.